Inflammation and risk of cardiovascular outcomes in atrial fibrillation and flutter patients: A Nationwide Registry Study
@adam_femerling@TorBiering@CTCPR_
https://t.co/QyMX1NU0ru
Great progress! We've reached 1/3 enrollment in the COLFIB trial: 167/500 afib patients! 🎉 This trial, randomizing between placebo & colchicine, aims to prove colchicine's cardioprotective capabilities. Stay tuned for results!#COLFIB#Arrhythmia#Colchicine@CTCPR_@TorBiering
@cardio_dk@drjohnm Thank you for a great lecture. Do you think chronic inflammation has a role in development and recurrence of afib? If so - is this a potential treatment target?
Loss ⬇️of peripheral pulmonary vasculature assessed by AI-assisted CT is associated with more severe AF burden and impaired 🫀-func and struct in AF pts. @AnneBjerg giving a brilliant talk at #ACC23@TorBiering@CopCard@ACCinTouch@drjohnm@cardio_dk